3-Year Supporting Data on TAVI in Low-Risk Patients: EVOLUT

Published Date: 08 Mar 2023

3-year results show that patients who underwent low-risk aortic valve replacement continue to report lower rates of all-cause mortality and stroke with TAVI compared to surgery

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Momelotinib, a JAK inhibitor, has FDA approval to treat adult myelofibrosis in anemic patients.

2.

If CD19 CAR T-Cell Therapy Fails in Lymphoma, Try a CD22 Version

3.

Older Adults With Advanced Cancer Prioritize Quality of Life

4.

Even a few mutated cells can significantly impact how blood cancers develop, study finds

5.

Q&A: When will individuals be able to receive customized cancer vaccines?


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot